ECL vs ELAB · P/E 35, rev $8.48B vs rev $2.0M
Ecolab Inc (ECL) versus Elevai Labs, Inc. Common Stock (ELAB) — a side-by-side from cached financials, not a winner call.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Elevai Labs, Inc. Common Stock (ELAB) is a biotechnology company listed on NASDAQ.
Latest reported ECL revenue for 2026-06-30 was $8.48B. Net income was $967.5M. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Latest reported ELAB revenue for 2026-06-30 was $2.0M. Net income was -$7.9M. ELAB currently screens at market cap $6.5M.
ECL currently screens at market cap $72.05B and trailing P/E 34.6. ELAB currently screens at market cap $6.5M.
Not investment advice. Open the ECL and ELAB stock pages for the full models.
Not investment advice.